Journal article
Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel
M Alexander, J King, A Bajel, C Doecke, P Fox, S Lingaratnam, JD Mellor, L Nicholson, I Roos, T Saunders, J Wilkes, R Zielinski, J Byrne, K Macmillan, A Mollo, S Kirsa, M Green
Internal Medicine Journal | Published : 2014
DOI: 10.1111/imj.12564
Abstract
These consensus guidelines provide recommendations for the safe handling of monoclonal antibodies. Definitive recommendations are given for the minimum safe handling requirements to protect healthcare personnel. The seven recommendations cover: (i) appropriate determinants for evaluating occupational exposure risk; (ii) occupational risk level compared with other hazardous and non-hazardous drugs; (iii) stratification of risk based on healthcare personnel factors; (iv) waste products; (v) interventions and safeguards; (vi) operational and clinical factors and (vii) handling recommendations. The seventh recommendation includes a risk assessment model and flow chart for institutions to conside..
View full abstractGrants
Funding Acknowledgements
The development of these guidelines was funded by Western and Central Melbourne Integrated Cancer Service (WCMICS) as part of a project commissioned to develop safe handling guidelines for novel anti-cancer agents.